Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
273
datasets available to search
ShareScore release 0.9.0
Dataset results
273 results for “Human immunodeficiency virus”
QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection
ClinicalTrials.gov study NCT00232908. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)
ClinicalTrials.gov study NCT06497504. IPD Sharing: YES. Countries: 10. Publications: 0.
MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)
ClinicalTrials.gov study NCT07042945. IPD Sharing: YES. Countries: 2. Publications: 0.
A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir®) and Dolutegravir (Tivicay®) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Act
ClinicalTrials.gov study NCT02527096. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Quitting Matters Human Immunodeficiency Virus Hybrid Trial
ClinicalTrials.gov study NCT06883097. IPD Sharing: NO. Countries: 1. Publications: 0.
Usability Study of a Self-test Prototype for Human Immunodeficiency Virus (HIV) Screening
ClinicalTrials.gov study NCT03979144. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-label, Follow-up of Doravirine/Islatravir (DOR/ISL 100 mg/0.75mg) for Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection (MK-8591A-033)
ClinicalTrials.gov study NCT04776252. IPD Sharing: YES. Countries: 16. Publications: 0.
Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)
ClinicalTrials.gov study NCT03572335. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Determine the Safety and Efficacy of Rilpivirine in Treatment-naive Indian Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection
ClinicalTrials.gov study NCT03563742. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054)
ClinicalTrials.gov study NCT01000818. IPD Sharing: YES. Countries: 0. Publications: 0.
Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Ages 4 Weeks to <12 Years and <45 kg (MK-1439-066)
ClinicalTrials.gov study NCT04375800. IPD Sharing: YES. Countries: 6. Publications: 0.
A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric Studies
ClinicalTrials.gov study NCT02494986. IPD Sharing: Not stated. Countries: 5. Publications: 0.
PRO 140 for Human Immunodeficiency Virus
ClinicalTrials.gov study NCT02438345. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Association Between Human Immunodeficiency Virus (HIV) Infection and Male Hypogonadism
ClinicalTrials.gov study NCT04760574. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Define Safety and Effectiveness of Dolutegravir (DTG) Use in Human Immunodeficiency Virus (HIV) Positive Pregnant Women
ClinicalTrials.gov study NCT03564613. IPD Sharing: NO. Countries: 1. Publications: 0.
Real-world Insights of People With Human Immunodeficiency Virus (HIV) Infection
ClinicalTrials.gov study NCT03400293. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (H
ClinicalTrials.gov study NCT05979311. IPD Sharing: YES. Countries: 17. Publications: 0.
Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)
ClinicalTrials.gov study NCT06134362. IPD Sharing: YES. Countries: 11. Publications: 0.
VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers
ClinicalTrials.gov study NCT04725877. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gut Associated Lymphatic Tissue (GALT) in HIV (Human Immunodeficiency Virus)- Infected Patients
ClinicalTrials.gov study NCT01679067. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.